Be sure to catch up on our latest webinar hosted by Dr. Michael Sy to explore the MSDA Test in a clinical setting. Watch now

Get in Touch

Research & Development

Octave is committed to providing cutting edge tools to support the monitoring and management of neurological diseases.

Featured Biology Publications

Nature Communications

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis. Read manuscript here. 

AUTHORS
Chitnis, T., Qureshi, F., Gehman, V. M., Becich, M., Bove, R., et al. (2024).

Proteomics Clinical Applications

Analytical validation of a multi-protein serum-based assay for disease activity assessments in multiple sclerosis. Read manuscript here.

AUTHORS
Qureshi, F., Hu, W., Loh, L., Patel, H., DeGuzman, M., et al. (2023).

Clinical Immunology

Clinical validation of the 18-protein Octave® MSDA Test. Read manuscript here. 

AUTHORS
Chitnis, T., Foley, J., Ionete, C., El Ayoubi, N. K., Saxena, S., et al. (2023).

Browse all of our latest publications

Changes in the Detection of Clinically Relevant White Matter Lesions in MS Using FDA-Cleared Automated Software

  • Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Imaging

Presentations

ACTRIMS

Download PDF

Analytical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Biology

MSDA

Presentations

ACTRIMS

Download PDF

Clinical Validation Study Results of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

  • Research Presented at the Annual ECTRIMS Meeting Virtual Conference — October 13-15, 2021

Biology

MSDA

Posters

ECTRIMS

Download PDF

Improving Patient Outcomes through a Comprehensive Care Management Platform Measuring Outcomes and Value: an Integrated, Novel solution for Generating insights in MS (MOVING MS)

  • Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Clinical

Posters

ACTRIMS

Clinical Disease Activity Status in Subjects with RRMS is Accurately Classified Using Multivariate Serum Protein Biomarker Models

  • Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019

Biology

MSDA

Posters

ECTRIMS

OMRF – ECTRIMS 2017 oral preso

Biology

MSDA

Presentations

1 … 9 10

© 2024 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us